175 related articles for article (PubMed ID: 35455390)
1. Pharmacokinetic Imaging Using
Marie S; Hernández-Lozano I; Le Vée M; Breuil L; Saba W; Goislard M; Goutal S; Truillet C; Langer O; Fardel O; Tournier N
Pharmaceuticals (Basel); 2022 Mar; 15(4):. PubMed ID: 35455390
[TBL] [Abstract][Full Text] [Related]
2. Repurposing
Marie S; Hernández-Lozano I; Langer O; Tournier N
J Nucl Med; 2021 Aug; 62(8):1043-1047. PubMed ID: 33674399
[TBL] [Abstract][Full Text] [Related]
3. Validation of Pharmacological Protocols for Targeted Inhibition of Canalicular MRP2 Activity in Hepatocytes Using [
Marie S; Hernández-Lozano I; Breuil L; Saba W; Novell A; Gennisson JL; Langer O; Truillet C; Tournier N
Pharmaceutics; 2020 May; 12(6):. PubMed ID: 32471244
[TBL] [Abstract][Full Text] [Related]
4. In vivo visualization and quantification of (Disturbed) Oatp-mediated hepatic uptake and Mrp2-mediated biliary excretion of 99mTc-mebrofenin in mice.
Neyt S; Huisman MT; Vanhove C; De Man H; Vliegen M; Moerman L; Dumolyn C; Mannens G; De Vos F
J Nucl Med; 2013 Apr; 54(4):624-30. PubMed ID: 23440558
[TBL] [Abstract][Full Text] [Related]
5. Transport mechanisms of hepatic uptake and bile excretion in clinical hepatobiliary scintigraphy with 99mTc-N-pyridoxyl-5-methyltryptophan.
Kobayashi M; Nakanishi T; Nishi K; Higaki Y; Okudaira H; Ono M; Tsujiuchi T; Mizutani A; Nishii R; Tamai I; Arano Y; Kawai K
Nucl Med Biol; 2014 Apr; 41(4):338-42. PubMed ID: 24607436
[TBL] [Abstract][Full Text] [Related]
6. Adenosine triphosphate-binding cassette subfamily C member 2 is the major transporter of the hepatobiliary imaging agent (99m)Tc-mebrofenin.
Bhargava KK; Joseph B; Ananthanarayanan M; Balasubramaniyan N; Tronco GG; Palestro CJ; Gupta S
J Nucl Med; 2009 Jul; 50(7):1140-6. PubMed ID: 19525466
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, in vitro and in vivo small-animal SPECT evaluation of novel technetium labeled bile acid analogues to study (altered) hepatic transporter function.
Neyt S; Vliegen M; Verreet B; De Lombaerde S; Braeckman K; Vanhove C; Huisman MT; Dumolyn C; Kersemans K; Hulpia F; Van Calenbergh S; Mannens G; De Vos F
Nucl Med Biol; 2016 Oct; 43(10):642-9. PubMed ID: 27513813
[TBL] [Abstract][Full Text] [Related]
8. Transporters involved in the hepatic uptake of (99m)Tc-mebrofenin and indocyanine green.
de Graaf W; Häusler S; Heger M; van Ginhoven TM; van Cappellen G; Bennink RJ; Kullak-Ublick GA; Hesselmann R; van Gulik TM; Stieger B
J Hepatol; 2011 Apr; 54(4):738-45. PubMed ID: 21163547
[TBL] [Abstract][Full Text] [Related]
9. Imaging-Based Characterization of a
Marie S; Hernández-Lozano I; Breuil L; Truillet C; Hu S; Sparreboom A; Tournier N; Langer O
Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34205780
[TBL] [Abstract][Full Text] [Related]
10. Use of tc-99m mebrofenin as a clinical probe to assess altered hepatobiliary transport: integration of in vitro, pharmacokinetic modeling, and simulation studies.
Ghibellini G; Leslie EM; Pollack GM; Brouwer KL
Pharm Res; 2008 Aug; 25(8):1851-60. PubMed ID: 18509604
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of (99m)technetium-mebrofenin and (99m)technetium-sestamibi as specific probes for hepatic transport protein function in rat and human hepatocytes.
Swift B; Yue W; Brouwer KL
Pharm Res; 2010 Sep; 27(9):1987-98. PubMed ID: 20652625
[TBL] [Abstract][Full Text] [Related]
12. Effect of Ritonavir on (99m)Technetium-Mebrofenin Disposition in Humans: A Semi-PBPK Modeling and In Vitro Approach to Predict Transporter-Mediated DDIs.
Pfeifer ND; Goss SL; Swift B; Ghibellini G; Ivanovic M; Heizer WD; Gangarosa LM; Brouwer KL
CPT Pharmacometrics Syst Pharmacol; 2013 Jan; 2(1):e20. PubMed ID: 23887590
[TBL] [Abstract][Full Text] [Related]
13. Regulation of hepatobiliary transport activity and noninvasive identification of cytokine-dependent liver inflammation.
Joseph B; Bhargava KK; Tronco GG; Kumaran V; Palestro CJ; Gupta S
J Nucl Med; 2005 Jan; 46(1):146-52. PubMed ID: 15632045
[TBL] [Abstract][Full Text] [Related]
14. Quantitative assessment of hepatic function during liver regeneration in a standardized rat model.
de Graaf W; Bennink RJ; Heger M; Maas A; de Bruin K; van Gulik TM
J Nucl Med; 2011 Feb; 52(2):294-302. PubMed ID: 21233172
[TBL] [Abstract][Full Text] [Related]
15. (99m)Tc-mebrofenin hepatobiliary scintigraphy with SPECT for the assessment of hepatic function and liver functional volume before partial hepatectomy.
de Graaf W; van Lienden KP; van Gulik TM; Bennink RJ
J Nucl Med; 2010 Feb; 51(2):229-36. PubMed ID: 20080899
[TBL] [Abstract][Full Text] [Related]
16. The roles of MRP2, MRP3, OATP1B1, and OATP1B3 in conjugated hyperbilirubinemia.
Keppler D
Drug Metab Dispos; 2014 Apr; 42(4):561-5. PubMed ID: 24459177
[TBL] [Abstract][Full Text] [Related]
17. Comparison between dynamic gadoxetate-enhanced MRI and
Rassam F; Zhang T; Cieslak KP; Lavini C; Stoker J; Bennink RJ; van Gulik TM; van Vliet LJ; Runge JH; Vos FM
Eur Radiol; 2019 Sep; 29(9):5063-5072. PubMed ID: 30796575
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte Concentrations of Imaging Compounds Associated with Transporter Inhibition: Evidence in Perfused Rat Livers.
Bonnaventure P; Cusin F; Pastor CM
Drug Metab Dispos; 2019 Apr; 47(4):412-418. PubMed ID: 30674615
[TBL] [Abstract][Full Text] [Related]
19. Liver Functional Volumetry by Tc-99m Mebrofenin Hepatobiliary Scintigraphy before Major Liver Resection: A Game Changer.
Gupta M; Choudhury PS; Singh S; Hazarika D
Indian J Nucl Med; 2018; 33(4):277-283. PubMed ID: 30386047
[TBL] [Abstract][Full Text] [Related]
20. Physiologically Based Pharmacokinetic Modeling of Transporter-Mediated Hepatic Disposition of Imaging Biomarker Gadoxetate in Rats.
Scotcher D; Melillo N; Tadimalla S; Darwich AS; Ziemian S; Ogungbenro K; Schütz G; Sourbron S; Galetin A
Mol Pharm; 2021 Aug; 18(8):2997-3009. PubMed ID: 34283621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
